During the initial phases of the transplant, the patient is at risk for developing mucositis, ulcerations, hemorrhage, infections and xerostomia. The acute oral complications will start to resolve a couple months after transplant and when the hematologic status begins to improve.
Patient’s receiving allogeneic bone marrow transplants or transplants from someone other than themselves are at risk for developing acute and chronic GVHD.
Some GVHD oral side effects include:
The goal of pre-BMT dental evaluation and treatment is to eliminate sources of infection and irritation. If dental treatment is needed, it will be scheduled in consultation with the oncologist.
Many patients will remain immunosuppressed for up to one year post-BMT and all elective dental work will be held until the patient has been deemed fit for treatment.